ALK-Abelló A/S
ALK-B
주식 순위
#2433
ALK-Abelló A/S is a global leader in allergy solutions, with operations... ALK-Abelló A/S is a global leader in allergy solutions, with operations spanning Europe, North America, and other international regions. The company offers a comprehensive portfolio of treatments for allergic rhinitis and allergic asthma, featuring key products such as GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX. ALK-Abelló specializes in allergy immunotherapy, providing options like injections, sublingual drops, and tablets to address a wide range of sensitivities, including those to grass, ragweed, house dust mites, Japanese cedar, various tree pollens, and certain foods. Furthermore, the company engages with consumers through a digital healthcare ecosystem, a platform designed to connect with allergy sufferers early in their journey, offering tools, e-commerce solutions, and guidance to support and streamline access to immunotherapy. ALK-Abelló also provides essential diagnostic allergy services, including skin prick and blood tests, alongside emergency treatments such as intramuscular adrenaline injections for severe, life-threatening allergic reactions like anaphylaxis. The company was established in 1923 and is based in Hørsholm, Denmark.
주가
$36.23
마지막 동기화: 2026-10-16
시가총액
$8.04B
변동 (1일)
-1.72%
변동 (1년)
12.00%
국가
DK
거래 ALK-Abelló A/S (ALK-B)
카테고리
Healthcare
의 시가총액 ALK-Abelló A/S(ALK-B)
시가총액: $8.04B
October 2026 기준으로 ALK-Abelló A/S의 시가총액은 $8.04B입니다. 이는 당사 데이터에 따르면 ALK-Abelló A/S이 세계에서 2433rd번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2009부터 2026까지 ALK-Abelló A/S의 시가총액 기록
